Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy: Evaluating cardiac contact distance as a predictor of cardiac exposure for patient selection N Rochet, JI Drake, K Harrington, JA Wolfgang, B Napolitano, BT Sadek, ... Practical radiation oncology 5 (3), e127-e134, 2015 | 87 | 2015 |
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center A Borogovac, A Keruakous, M Bycko, J Holter Chakrabarty, S Ibrahimi, ... Bone marrow transplantation 57 (6), 1025-1027, 2022 | 39 | 2022 |
Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment MN Shenouda, BT Sadek, SI Goldberg, AR Keruakous, BJ Croft, ... Clinical breast cancer 14 (3), 198-204, 2014 | 23 | 2014 |
The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy … AR Keruakous, BT Sadek, MN Shenouda, A Niemierko, RF Abi Raad, ... Breast cancer research and treatment 146, 365-370, 2014 | 15 | 2014 |
Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary? BT Sadek, MN Shenouda, RF Abi Raad, A Niemierko, AR Keruakous, ... International Journal of Radiation Oncology* Biology* Physics 87 (4), 726-730, 2013 | 15 | 2013 |
Azacitidine maintenance therapy post-allogeneic stem cell transplantation in poor-risk acute myeloid leukemia AR Keruakous, J Holter-Chakrabarty, SA Schmidt, MO Khawandanah, ... Hematology/oncology and stem cell therapy, 2021 | 14 | 2021 |
Clinical considerations for immunoparesis in multiple myeloma M Chahin, Z Branham, A Fox, C Leurinda, AR Keruakous Cancers 14 (9), 2278, 2022 | 7 | 2022 |
Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma AR Keruakous, A Asch, R Aljumaily, D Zhao, C Yuen Transplant immunology 71, 101544, 2022 | 6 | 2022 |
Successful development of an outpatient chimeric antigen receptor (CAR) T cell therapy program A Borogovac, AR Keruakous, M Bycko, JH Chakrabarty, S Ibrahimi, ... Blood 138, 4821, 2021 | 6 | 2021 |
Venetoclax-induced tumor lysis syndrome in acute myeloid leukemia: Real world experience. A Keruakous, R Saleem, AS Asch Journal of Clinical Oncology 38 (15_suppl), e19542-e19542, 2020 | 5 | 2020 |
Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins? BT Sadek, G Homayounfar, RF Abi Raad, A Niemierko, MN Shenouda, ... Breast cancer research and treatment 154, 71-79, 2015 | 5 | 2015 |
Pain management in oncology patients amidst the opioid epidemic: How to minimize non-medical opioid Use M Chahin, S Matosz, I Khalel, S Day, A Keruakous Cureus 13 (11), 2021 | 3 | 2021 |
Hypomethylating agent maintenance therapy after allogeneic stem cell transplant improves transplant outcome in high risk acute myelogenous leukemia AR Keruakous, JH Chakrabarty, SA Schmidt, MO Khawandanah, G Selby, ... Blood 134, 3297, 2019 | 3 | 2019 |
Academic center outreach to community practices increases transplant referrals and possibly reduce racial disparities V Kota, T Anwar, S Malhotra, T Anwar, M Anwar, S Jimenez, C Corley, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | 2 | 2022 |
Effect of Community and Socio-Economic Factors on Cardiovascular, Cancer and Cardio-Oncology Patients with COVID-19 A Batra, J Swaby, P Raval, H Zhu, NL Weintraub, M Terris, NA Karim, ... COVID 2 (3), 350-368, 2022 | 2 | 2022 |
Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant AR Keruakous, P Balakrishna, SA Schmidt, MT Autry, A Asch Annals of Hematology 100, 1629-1630, 2021 | 1 | 2021 |
Disease biology alters the response to frontline bortezomib, lenalidomide and dexamethasone in Multiple Myeloma AR Keruakous, S Day, C Yuen Glob J Cancer Ther 7 (1), 010-015, 2021 | 1 | 2021 |
Improving clinical outcomes in multiple myeloma: Weight maintenance strategies to reduce complications during autologous hematopoietic transplantation. A Shah, D Bradshaw, V Shah, M Dalgetty, S Athota, F Boghani, M Stokes, ... Journal of Clinical Oncology 42 (16_suppl), e19533-e19533, 2024 | | 2024 |
Unveiling oncologists' geographical journey: Analyzing hematology/oncology fellowship graduates' relocation patterns and their impact on regional disparities in cancer care. R Patel, AR Keruakous, R Vuppala, C Nulu, C Weeks, ... Journal of Clinical Oncology 42 (16_suppl), 9006-9006, 2024 | | 2024 |
Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2 Z Brown, C Scott, LF Zhang, R Sadek, A Clarke, A Jillella, AR Keruakous, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |